Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1990 2
1991 1
1992 1
1993 3
1994 4
1995 2
1996 1
1997 2
1998 7
1999 13
2000 8
2001 7
2002 14
2003 6
2004 6
2005 14
2006 13
2007 13
2008 10
2009 16
2010 13
2011 12
2012 14
2013 12
2014 21
2015 19
2016 19
2017 20
2018 32
2019 25
2020 25
2021 15
2022 16
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

363 results

Results by year

Filters applied: . Clear all
Page 1
Emergencies in haematology: tumour lysis syndrome.
Durani U, Hogan WJ. Durani U, et al. Br J Haematol. 2020 Feb;188(4):494-500. doi: 10.1111/bjh.16278. Epub 2019 Nov 27. Br J Haematol. 2020. PMID: 31774551 Free article. Review.
The syndrome consists of laboratory abnormalities either alone (laboratory TLS) or with clinical sequelae including renal failure, seizures, and arrhythmias (clinical TLS). Clinical TLS is a predictor for worse overall morbidity and mortality in cancer patients, but can be …
The syndrome consists of laboratory abnormalities either alone (laboratory TLS) or with clinical sequelae including renal failure, seizures, …
Tumour lysis syndrome.
Calvo Villas JM. Calvo Villas JM. Med Clin (Barc). 2019 May 17;152(10):397-404. doi: 10.1016/j.medcli.2018.10.029. Epub 2019 Jan 3. Med Clin (Barc). 2019. PMID: 30612747 Review. English, Spanish.
Hyperleukocytosis and leukostasis: management of a medical emergency.
Giammarco S, Chiusolo P, Piccirillo N, Di Giovanni A, Metafuni E, Laurenti L, Sica S, Pagano L. Giammarco S, et al. Expert Rev Hematol. 2017 Feb;10(2):147-154. doi: 10.1080/17474086.2017.1270754. Epub 2016 Dec 26. Expert Rev Hematol. 2017. PMID: 27967252 Review.
Areas covered: Risk factors include younger age, myelomonocytic or monocytic/monoblastic morphology, microgranular variant of acute promyelocitic leukemia and T-cell ALL, and some cytogenetic abnormalities. Poor prognosis due to high early death rate secondary to leukostas …
Areas covered: Risk factors include younger age, myelomonocytic or monocytic/monoblastic morphology, microgranular variant of acute promyelo …
Pediatric Hematologic and Oncologic Emergencies.
Stephanos K, Dubbs SB. Stephanos K, et al. Emerg Med Clin North Am. 2021 Aug;39(3):555-571. doi: 10.1016/j.emc.2021.04.007. Epub 2021 Jun 9. Emerg Med Clin North Am. 2021. PMID: 34215402 Review.
Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
Matuszkiewicz-Rowinska J, Malyszko J. Matuszkiewicz-Rowinska J, et al. Kidney Blood Press Res. 2020;45(5):645-660. doi: 10.1159/000509934. Epub 2020 Sep 30. Kidney Blood Press Res. 2020. PMID: 32998135 Free article. Review.
One must remember that in TLS, the threshold for RRT initiation may be lower than in other clinical situations since the process of cell breakdown is ongoing, and rapid increases in serum electrolytes cannot be predicted....
One must remember that in TLS, the threshold for RRT initiation may be lower than in other clinical situations since the process of cell bre …
The treatment of Burkitt lymphoma in adults.
Crombie J, LaCasce A. Crombie J, et al. Blood. 2021 Feb 11;137(6):743-750. doi: 10.1182/blood.2019004099. Blood. 2021. PMID: 33171490 Free article. Review.
Leukemia: an overview for primary care.
Davis AS, Viera AJ, Mead MD. Davis AS, et al. Am Fam Physician. 2014 May 1;89(9):731-8. Am Fam Physician. 2014. PMID: 24784336 Free article. Review.
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.
Roschewski M, Dunleavy K, Abramson JS, Powell BL, Link BK, Patel P, Bierman PJ, Jagadeesh D, Mitsuyasu RT, Peace D, Watson PR, Hanna WT, Melani C, Lucas AN, Steinberg SM, Pittaluga S, Jaffe ES, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Fanale MA, Noy A, Wilson WH. Roschewski M, et al. J Clin Oncol. 2020 Aug 1;38(22):2519-2529. doi: 10.1200/JCO.20.00303. Epub 2020 May 26. J Clin Oncol. 2020. PMID: 32453640 Free PMC article.
The primary endpoint was event-free survival (EFS), and secondary endpoints were toxicity and predictors of EFS and overall survival (OS). RESULTS: Between 2010 and 2017, 113 patients were enrolled across 22 centers, and 98 (87%) were high risk. ...Therapy was equally effe …
The primary endpoint was event-free survival (EFS), and secondary endpoints were toxicity and predictors of EFS and overall survival …
Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP, Zeidan AM. Bewersdorf JP, et al. Cells. 2020 Oct 17;9(10):2310. doi: 10.3390/cells9102310. Cells. 2020. PMID: 33080779 Free PMC article. Review.
Up to 18% of patients with acute myeloid leukemia (AML) present with a white blood cell (WBC) count of greater than 100,000/L, a condition that is frequently referred to as hyperleukocytosis. Hyperleukocytosis has been associated with an adverse prognosis and a higher inci …
Up to 18% of patients with acute myeloid leukemia (AML) present with a white blood cell (WBC) count of greater than 100,000/L, a condition t …
363 results